143

Neurology
Focuses on brain health.
Sub Categories on Neurology
Latest Articles
It is not clear whether new Alzheimer's drugs will make a difference at a population level, say researchers

It is not clear whether new Alzheimer's drugs will make a difference at a population level, say researchers

byUniversity of CambridgeCredit: CC0 Public DomainCambridge researchers have cast doubt on whether new amyloid immunotherapy drugs will have the desired effect of significantly reducing the impa

It is not clear whether new Alzheimer's drugs will make a difference at a population level, say researchers

byUniversity of CambridgeCredit: CC0 Public DomainCambridge researchers have cast doubt on whether new amyloid immunotherapy drugs will have the desired effect of significantly reducing the impa
Skin cells from frontotemporal dementia patients may reveal disease mechanisms and biomarkers for drug research

Skin cells from frontotemporal dementia patients may reveal disease mechanisms and biomarkers for drug research

by University of Eastern FinlandFibroblasts of C9-HRE carriers show unaltered C9orf72 levels, express RNA foci, but do not display DPR proteins. a TaqMan assay from fibroblast RNA for C9orf72 all

Skin cells from frontotemporal dementia patients may reveal disease mechanisms and biomarkers for drug research

by University of Eastern FinlandFibroblasts of C9-HRE carriers show unaltered C9orf72 levels, express RNA foci, but do not display DPR proteins. a TaqMan assay from fibroblast RNA for C9orf72 all
What an animated taco reveals about curiosity and patience

What an animated taco reveals about curiosity and patience

byDuke UniversityCredit: Pixabay/CC0 Public DomainCuriosity paradoxically increases people's patience for an answer, while simultaneously making them more eager to hear it, finds a new study

What an animated taco reveals about curiosity and patience

byDuke UniversityCredit: Pixabay/CC0 Public DomainCuriosity paradoxically increases people's patience for an answer, while simultaneously making them more eager to hear it, finds a new study
How much does dementia risk increase after traumatic brain injury?

How much does dementia risk increase after traumatic brain injury?

by Public Library of ScienceThe WHO has predicted that TBI will become a leading cause of death and long-term illness during the next ten years. Already one per cent of the population in the United St

How much does dementia risk increase after traumatic brain injury?

by Public Library of ScienceThe WHO has predicted that TBI will become a leading cause of death and long-term illness during the next ten years. Already one per cent of the population in the United St
Dementia study reveals how toxic proteins spread through brain

Dementia study reveals how toxic proteins spread through brain

by University of EdinburghGraphical Abstract. Credit:Neuron(2023). DOI: 10.1016/j.neuron.2023.04.020Fresh insights into the spread of damaging proteins that build up in the brains of

Dementia study reveals how toxic proteins spread through brain

by University of EdinburghGraphical Abstract. Credit:Neuron(2023). DOI: 10.1016/j.neuron.2023.04.020Fresh insights into the spread of damaging proteins that build up in the brains of
Tiny blood vessels in the brain could be the key in treating vascular dementia

Tiny blood vessels in the brain could be the key in treating vascular dementia

by University of SouthamptonTiny blood vessels in the brain could be the key in treating vascular dementia. Credit: University of SouthamptonResearchers from the University of Southampton are to

Tiny blood vessels in the brain could be the key in treating vascular dementia

by University of SouthamptonTiny blood vessels in the brain could be the key in treating vascular dementia. Credit: University of SouthamptonResearchers from the University of Southampton are to
Amyloid is a less accurate marker for measuring severity, progression of Alzheimer's

Amyloid is a less accurate marker for measuring severity, progression of Alzheimer's

by Perelman School of Medicine at the University of PennsylvaniaPET imaging using the radiotracers FDG and florbetapir to quantify cognitive decline in patients with Alzheimer’s disease (AD), mil

Amyloid is a less accurate marker for measuring severity, progression of Alzheimer's

by Perelman School of Medicine at the University of PennsylvaniaPET imaging using the radiotracers FDG and florbetapir to quantify cognitive decline in patients with Alzheimer’s disease (AD), mil
Molecular pathology of suicide: A postmortem study

Molecular pathology of suicide: A postmortem study

byUniversity of AmsterdamCredit: Pixabay/CC0 Public DomainWhat changes in the brains of people who commit or think about committing suicide? Ph.D. candidate Lin Zhang investigated at a molecular

Molecular pathology of suicide: A postmortem study

byUniversity of AmsterdamCredit: Pixabay/CC0 Public DomainWhat changes in the brains of people who commit or think about committing suicide? Ph.D. candidate Lin Zhang investigated at a molecular
Clinical trial results for lecanemab are a significant step for Alzheimer's, but not a historic breakthrough

Clinical trial results for lecanemab are a significant step for Alzheimer's, but not a historic breakthrough

by University of New South WalesAmyloid plaques and neurofibrillary tangles occur in the brains of patients with Alzheimer's disease. Credit: Ian JosonPartner companies Eisai and Biogen recen

Clinical trial results for lecanemab are a significant step for Alzheimer's, but not a historic breakthrough

by University of New South WalesAmyloid plaques and neurofibrillary tangles occur in the brains of patients with Alzheimer's disease. Credit: Ian JosonPartner companies Eisai and Biogen recen
Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement
Testing memory over four weeks could predict Alzheimer's disease risk

Testing memory over four weeks could predict Alzheimer's disease risk

by University of BristolCredit: CC0 Public DomainNew research suggests testing people's memory over four weeks could identify who is at higher risk of developing Alzheimer's disease befor

Testing memory over four weeks could predict Alzheimer's disease risk

by University of BristolCredit: CC0 Public DomainNew research suggests testing people's memory over four weeks could identify who is at higher risk of developing Alzheimer's disease befor
Extra-large synapses could be a cause of schizophrenia

Extra-large synapses could be a cause of schizophrenia

by RIKENExtra-strong synapses could play an important role in psychiatric disorders such as schizophrenia, a study by RIKEN researchers finds. Credit: Equinox Graphics/Science Photo LibrarySchizo

Extra-large synapses could be a cause of schizophrenia

by RIKENExtra-strong synapses could play an important role in psychiatric disorders such as schizophrenia, a study by RIKEN researchers finds. Credit: Equinox Graphics/Science Photo LibrarySchizo